Showing 971-980 of 1783 results for "".
New and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
https://reachmd.com/programs/cme/new-and-emerging-pah-therapies-and-approaches-a-mixture-of-hope-and-complexity/36095/There are new and emerging therapies for PAH. Hear our experts discuss treatment approaches and why making the right diagnosis is key for selecting and individualizing therapy.Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer
https://reachmd.com/programs/cme/pulmonary-hypertension-getting-the-right-diagnosis-and-knowing-when-to-refer/36094/Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to ReferAdvances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
https://reachmd.com/programs/cme/advances-in-the-treatment-of-neuropsychiatric-symptoms-of-alzheimers-disease-early-recognition-diagnosis-and-innovative-emerging-therapies/35728/Join us to learn about the diagnosis of NPS associated with Alzheimer’s disease, as well as current and emerging agents for treatment.Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
https://reachmd.com/programs/cme/resectable-head-neck-cancer-a-team-based-approach-to-perioperative-immunotherapy/35705/Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative ImmunotherapyAdvancing Care in Locally Advanced HNSCC: Integrating Perioperative Immunotherapy and Multimodal Strategies
https://reachmd.com/programs/cme/advancing-care-in-locally-advanced-hnscc-integrating-perioperative-immunotherapy-and-multimodal-strategies/35704/Explore perioperative immunotherapy and multimodal strategies to optimize patient outcomes in resectable locally advanced head and neck squamous cell carcinoma.Rethinking MacTel: Cell-based Insights for Vision Preservation
https://reachmd.com/programs/cme/Rethinking-MacTel-Cell-Based-Insights-for-Vision-Preservation/35524/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence®
https://reachmd.com/programs/cme/unresectable-hcc-an-emerging-era-of-combination-therapy-a-clinical-convergence/12029/Don’t miss this opportunity to learn more about combination strategies, with practical guidance on their integration into clinical practice.Dr. Google Is a Liar
https://reachmd.com/programs/book-club/dr-google-liar/10612/With many patients turning to the internet for the answer to their symptoms and ailments, how can we as healthcare providers win the information war?Conquer the Clutter: Strategies to Identify, Manage, & Overcome Hoarding
https://reachmd.com/programs/book-club/conquer-the-clutter-strategies-to-identify-manage-overcome-hoarding/11245/As many as 21 million Americans may be living with hoarding disorder. How can we help them reclaim their lives from the clutter that’s taken over?The Hidradenitis Suppurativa Therapeutic Pipeline
https://reachmd.com/topics/rare-disease/the-hidradenitis-suppurativa-therapeutic-pipeline/54824/Though treatment options are currently limited, the pipeline for HS therapeutics is active with numerous medications in development.